<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03137706</url>
  </required_header>
  <id_info>
    <org_study_id>0S-16-1</org_study_id>
    <secondary_id>NCI-2016-01955</secondary_id>
    <secondary_id>0S-16-1</secondary_id>
    <secondary_id>P30CA014089</secondary_id>
    <nct_id>NCT03137706</nct_id>
  </id_info>
  <brief_title>Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer</brief_title>
  <official_title>Characterization of Mechanical Tissue Properties in Pancreas, Liver and Colon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Southern California</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot research trial studies characterization of mechanical tissue properties in&#xD;
      patients with pancreatic, liver, or colon cancer. Mechanical properties and stiffness of the&#xD;
      cancerous tissue may be correlated with the standard pathology report that describes the&#xD;
      stage of the disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. To determine if our optical polarimeter device is able to measure tissue stiffness across&#xD;
      several human cancer types ex vivo.&#xD;
&#xD;
      SECONDARY OBJECTIVES:&#xD;
&#xD;
      I. To describe the inter- and intra-tumor heterogeneity of tissue stiffness. II. To determine&#xD;
      if the measurements made by the optical polarimeter device are non-destructive.&#xD;
&#xD;
      TERTIARY OBJECTIVES:&#xD;
&#xD;
      I. Perform multi-variable cross-correlation statistical analysis to determine relationships&#xD;
      between: tissue stiffness characteristics, molecular level signatures, and cellular level&#xD;
      properties, and if numbers permit, response to treatment.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients undergo fresh tumor tissue collection at the time of surgery. The fresh tumor tissue&#xD;
      samples are analyzed for tissue stiffness measurements using an optical polarimeter device&#xD;
      and cell viability using an automated cell counter.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient accrual&#xD;
  </why_stopped>
  <start_date type="Actual">November 14, 2016</start_date>
  <completion_date type="Actual">October 19, 2020</completion_date>
  <primary_completion_date type="Actual">October 19, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Young's modulus (stiffness) on fresh tissue</measure>
    <time_frame>Up to 15 months</time_frame>
    <description>A portable optical fiber polarimetric sensor device to measure the Young's modulus in tissue samples will be used.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">8</enrollment>
  <condition>Colon Carcinoma</condition>
  <condition>Liver and Intrahepatic Bile Duct Carcinoma</condition>
  <condition>Pancreatic Carcinoma</condition>
  <arm_group>
    <arm_group_label>Ancillary-correlative (tissue stiffness analysis)</arm_group_label>
    <description>Patients undergo fresh tumor tissue collection at the time of surgery. The fresh tumor tissue samples are analyzed for tissue stiffness measurements using optical polarimeter device and cell viability using automated cell counter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biospecimen Collection</intervention_name>
    <description>Undergo fresh tumor tissue collection</description>
    <arm_group_label>Ancillary-correlative (tissue stiffness analysis)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Biomarker Analysis</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Ancillary-correlative (tissue stiffness analysis)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Procedure</intervention_name>
    <description>Tissue stiffness and cell viability analysis</description>
    <arm_group_label>Ancillary-correlative (tissue stiffness analysis)</arm_group_label>
    <other_name>Lab Test</other_name>
    <other_name>Lab Tests</other_name>
    <other_name>Laboratory Test</other_name>
    <other_name>Test</other_name>
    <other_name>Tests</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tissue&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for surgery to remove primary tumors in the pancreas, liver, or colon&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Scheduled for surgery to remove primary tumors in the pancreas, liver or colon and&#xD;
             have not undergone any prior treatment&#xD;
&#xD;
          -  Ability to understand and the willingness to sign a written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women will not be consented&#xD;
&#xD;
          -  Patients that are unable to consent for surgery&#xD;
&#xD;
          -  Primary liver tumors with cirrhosis will be excluded from this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shannon Mumenthaler, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southern California</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>USC / Norris Comprehensive Cancer Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 29, 2017</study_first_submitted>
  <study_first_submitted_qc>April 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2017</study_first_posted>
  <last_update_submitted>April 1, 2021</last_update_submitted>
  <last_update_submitted_qc>April 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Ductal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

